Last reviewed · How we verify
Non-Lipid Artificial Tear — Competitive Intelligence Brief
marketed
Artificial tear / Ophthalmic lubricant
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Non-Lipid Artificial Tear (Non-Lipid Artificial Tear) — University of Seville. A non-lipid artificial tear formulation that lubricates and protects the ocular surface by mimicking natural tear composition without lipid components.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Non-Lipid Artificial Tear TARGET | Non-Lipid Artificial Tear | University of Seville | marketed | Artificial tear / Ophthalmic lubricant |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Artificial tear / Ophthalmic lubricant class)
- University of Seville · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Non-Lipid Artificial Tear CI watch — RSS
- Non-Lipid Artificial Tear CI watch — Atom
- Non-Lipid Artificial Tear CI watch — JSON
- Non-Lipid Artificial Tear alone — RSS
- Whole Artificial tear / Ophthalmic lubricant class — RSS
Cite this brief
Drug Landscape (2026). Non-Lipid Artificial Tear — Competitive Intelligence Brief. https://druglandscape.com/ci/non-lipid-artificial-tear. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab